Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Oct 12, 2026 | Fund Letter | Haruki Toyama, Andy Romanowich, Rich EisingerMadison Mid Cap Fund | Revvity Inc. $RVTY• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Long RVTY (Revvity, Inc.) Life sciences supplier Revvity, a new holding in the portfolio, performed well as orders from their core pharma and biotech customers are increasing, partly attributable to AI enhancements in their workflow. We also purchased... | BULL | View Pitch → |
| Aug 21, 2026 | Fund Letter | Gary H. MillerSycamore Mid Cap Value Equity | Revvity Inc. $RVTY• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Long RVTY (Revvity, Inc.) Revvity, Inc. (RVTY), a provider of life sciences and diagnostics tools, was another detractor for the quarter. Early in the... | BULL | View Pitch → |
| Aug 21, 2026 | Fund Letter | Stephen Dodson and Raphael de BalmannBretton Fund | Revvity Inc. $RVTY• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Long RVTY (Revvity, Inc.) Revvity—the former PerkinElmer—has been on a roller coaster ride the last few years. It generated windfall... | BULL | View Pitch → |
| Feb 20, 2026 | Fund Letter | Stephen Dodson and Raphael de BalmannBretton Fund | Revvity Inc. $RVTY• NASDAQ | Life Sciences Tools & ServicesLife Sciences Tools & Services | Bretton Fund 2025 Q4 (RVTY) Revvity We invested in the former PerkinElmer in the wake of Covid. In many ways... | BEAR | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.